首页> 外文期刊>Cell death & disease. >HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA
【24h】

HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA

机译:从霍乱毒素佐剂破坏的肠上皮释放的HMGB1有助于粘膜树突状细胞的活化和肠细胞毒性T淋巴细胞和IgA的诱导

获取原文
获取外文期刊封面目录资料

摘要

Cholera toxin (CT) is a potent mucosal adjuvant and oral administration of ovalbumin (OVA) antigens plus CT induces OVA-specific CD8+ cytotoxic T lymphocytes (CTLs) and IgA production in intestinal mucosa. However, the mechanisms of induction of these immune responses remain unknown. Intestinal OVA-specific CD8+ CTLs were not induced by oral administration of the CT active (CTA) or CT binding (CTB) subunit as an adjuvant and CD11c+ DCs were involved in cross-priming of intestinal CTLs. CD8+CD103+CD11c+CD11b?DCs and DCIR2+CD103+CD11c+CD11b+ DCs were distributed in the intestinal lamina propria and mesenteric lymph nodes, both DC subsets expressed DEC-205, and the expression of co-stimulatory molecules such as CD80 and CD86 was enhanced in both DC subsets after oral administration of intact CT but not the CTA or CTB subunit. Intestinal DCs activated by the oral administration of OVA plus CT cross-presented OVA antigens and DCs that captured OVA antigen through DEC-205, but not DCIR2, could cross-present antigen. We found that oral administration of intact CT, but not the CTA or CTB subunit, enhanced cell death, cytoplasmic expression of high-mobility group box 1 protein (HMGB1) in epithelial cell adhesion molecule (EpCAM)+CD45? intestinal epithelial cells (IECs), and HMGB1 levels in fecal extracts. HMGB1 dose-dependently enhanced the expression of CD80 and CD86 on DCs in vitro, and intravenous or oral administration of glycyrrhizin, an HMGB1 inhibitor, significantly suppressed activation of mucosal DCs and induction of intestinal OVA-specific CTLs and IgA by oral CT administration. These results showed that oral administration of intact CT triggers epithelial cell death in the gut and the release of HMGB1 from damaged IECs, and that the released HMGB1 may mediate activation of mucosal DCs and induction of CTLs and IgA in the intestine.
机译:霍乱毒素(CT)是一种有效的粘膜佐剂,口服卵清蛋白(OVA)抗原加上CT可以在肠道粘膜中诱导OVA特异性CD8 +细胞毒性T淋巴细胞(CTL)和IgA的产生。但是,这些免疫应答的诱导机制仍然未知。肠内OVA特异性CD8 + CTL不能通过口服给予CT活性(CTA)或CT结合(CTB)亚基作为佐剂来诱导,而CD11c + DC参与肠内CTL的交叉引发。 CD8 + CD103 + CD11c + CD11b + DCs和DCIR2 + CD103 + CD11c + CD11b + DCs分布在肠固有层和肠系膜淋巴结中,两个DC亚群均表达DEC-205,并表达共刺激分子,例如CD80和口服完整CT后,两个DC亚组中的CD86均增强,但CTA或CTB亚基未增强。通过口服OVA加CT激活的肠道DC交叉呈递OVA抗原,而通过DEC-205捕获OVA抗原而不通过DCIR2捕获的DC可以交叉呈递抗原。我们发现口服完整的CT而不是CTA或CTB亚基可以增加细胞死亡,上皮细胞粘附分子(EpCAM)+ CD45中高迁移率族1号框蛋白(HMGB1)的细胞质表达?粪便提取物中的肠上皮细胞(IEC)和HMGB1水平。 HMGB1剂量依赖性地增强了DC在体外DC上的CD80和CD86的表达,并且通过静脉或口服HMGB1抑制剂甘草甜素显着抑制了粘膜DC的活化以及通过口服CT给药诱导肠内OVA特异性CTL和IgA的诱导。这些结果表明,口服完整的CT可以触发肠道上皮细胞死亡,并从受损的IECs释放HMGB1,释放的HMGB1可能介导粘膜DC的激活以及肠中CTL和IgA的诱导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号